A surgical perspective on positron emission tomography

Journal of Surgical Oncology

Volumn 95, Issue 6, 2007, Pages 443-446

  Gulec, Seza A ^a,b  

^a Goshen Health System   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROTHYMIDINE F 18; RADIOPHARMACEUTICAL AGENT; THYMIDINE C 11; UNCLASSIFIED DRUG;

BIOACCUMULATION; BREAST CANCER; CANCER DIAGNOSIS; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EDITORIAL; HUMAN; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; THYROID CANCER;

EID: 34248218219     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20667     Document Type: Editorial

References (3)

1. Warburg O. On the Origin of Cancer Cells. Science 1956;123:309-314.
2. Juweid ME, Cheson BD: Positron Emission Tomography and Assessment of Cancer Therapy. N Engl J Med 2006;354:496-507.
3. Gatenby RA, Gawlinski ET: The Glycolytic Phenotype in Carcinogenesis and Tumor Invasion: Insights through Mathematical Models. Cancer Res 2003;63:3847-3854.